BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37605580)

  • 1. CircZSWIM4 facilitates tumor development in lung adenocarcinoma by targeting miR-370-3p and miR-873-5p to regulate the axis of FOXM1/β-catenin.
    Fan Z; Wang H
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):132-140. PubMed ID: 37605580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA LINC01006 Facilitates Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma via Targeting the MicroRNA 129-2-3p/CTNNB1 Axis and Activating Wnt/β-Catenin Signaling Pathway.
    Zhang Y; Liu H; Zhang Q; Zhang Z
    Mol Cell Biol; 2021 May; 41(6):e0038020. PubMed ID: 33753463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
    Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
    Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y
    Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
    Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
    Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis.
    Tian S; Han G; Lu L; Meng X
    World J Surg Oncol; 2020 Mar; 18(1):56. PubMed ID: 32183822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
    Yang B; Zhang B; Qi Q; Wang C
    BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y; Shen H
    Biomed Pharmacother; 2019 Mar; 111():1367-1375. PubMed ID: 30841451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-MMP2 (circ-0039411) induced by FOXM1 promotes the proliferation and migration of lung adenocarcinoma cells in vitro and in vivo.
    Lv X; Huang H; Feng H; Wei Z
    Cell Death Dis; 2020 Jun; 11(6):426. PubMed ID: 32513952
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang G; Wang X; Jin Y
    Cancer Biother Radiopharm; 2019 Nov; 34(9):572-580. PubMed ID: 31644316
    [No Abstract]   [Full Text] [Related]  

  • 17. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
    Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
    Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.